Term Name: | eriodictyol 7-O-beta-D-glucopyranoside |
---|---|
Synonyms: | (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl beta-D-glucopyranoside, (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside, (2S)-eriodictyol 7-O-beta-D-glucopyranoside, (2S)-eriodictyol-7-O-beta-D-glucopyranoside, 3',4',5,7-tetrahydroxyflavanone 7-beta-D-glucopyranoside, 5,7,3',4'-tetrahydroxyflavanone 7-O-glucoside, eriodictyol 7-beta-D-glucoside, eriodictyol 7-O-beta-D-glucoside, eriodictyol-7-O-beta-D-glucoside, eriodictyol-7-O-glucoside, miscanthoside |
Definition: | A flavanone glycoside that is eriodictyol attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is an Nrf2 activator and provides protection against cisplatin-induced toxicity. |
Ontology: | ChEBI [CHEBI:139458] ( EBI ) |